Tl. Doering et al., TOXICITY OF MYRISTIC ACID ANALOGS TOWARD AFRICAN TRYPANOSOMES, Proceedings of the National Academy of Sciences of the United Statesof America, 91(21), 1994, pp. 9735-9739
New drugs are needed for treatment of diseases caused by African trypa
nosomes. One possible target for chemotherapy is the biosynthesis of t
he glycosyl phosphatidylinositol (GPI) of this parasite's variant surf
ace glycoprotein (VSG). Unlike mammalian GPIs, the diacylglycerol moie
ty of the VSG anchor contains only myristate (tetradecanoate), added i
n unique remodeling reactions. We previously found that 11-oxatetradec
anoic acid [i.e., 10-(propoxy)decanoic acid] is selectively toxic to t
rypanosomes. We have now assayed 244 different fatty acid analogs, mos
t with chain lengths comparable to that of myristate, for trypanocidal
effects. In these assays we surveyed the effects on toxicity of syste
matic alterations in the analogs' steric, conformational, and hydropho
bic properties. We also used three H-3-labeled oxatetradecanoic acids
to explore the mechanism of analog action. Their incorporation into VS
G correlated roughly with toxicity, although they also were incorporat
ed into phospholipids and other proteins. Myristate analogs are useful
for studying the mechanism of GPI myristoylation, and they are candid
ates for antitrypanosomal chemotherapy.